Sepsis and Antimicrobial Stewardship: Safeguarding Lives through Responsible Treatment

By, SRIRAM

Introduction:

Sepsis is a life-threatening condition that arises when the body's response to infection becomes dysregulated, leading to organ dysfunction and potentially death. It is a global health concern that affects millions of people each year. Effective management of sepsis requires prompt and appropriate antimicrobial therapy, but the rising threat of antimicrobial resistance necessitates a careful and responsible approach. 

Antimicrobial therapy is an essential part of sepsis management, focusing on timely recognition and resuscitation pathways(3). Antimicrobial stewardship aims to achieve optimal clinical outcomes, cost-effectiveness, and reduced consequences such as toxic effects, pathogen selection, and resistance(1). This article explores the role of antimicrobial stewardship in sepsis, emphasizing the importance of responsible prescribing practices to mitigate unintended consequences and improve patient outcomes.

The Importance of Antimicrobial Therapy:

Antimicrobial therapy plays a pivotal role in sepsis treatment by targeting the underlying infection. Timely administration of appropriate antibiotics is crucial to control the infection and improve patient survival rates. However, the overuse, misuse, and inappropriate prescribing of antimicrobials have contributed to the emergence of antimicrobial resistance—a global crisis that threatens the effectiveness of these life-saving drugs.

Antimicrobial Stewardship Strategies in Sepsis:

To prevent unintended consequences of inappropriate antimicrobial prescribing in sepsis, antimicrobial stewardship strategies should be a fundamental part of quality improvement initiatives(3). These strategies include de-escalation protocols and stopping antimicrobials in non-infective cases, aiming to minimize antimicrobial resistance and healthcare-associated infections like Clostridioides difficile infection(1). These programs encourage responsible prescribing practices, such as appropriate selection, dosage, and duration of antimicrobials, with the goal of maximizing patient outcomes while minimizing resistance.

Achieving Balance in Sepsis and Antimicrobial Stewardship:

Finding an appropriate balance between sepsis management and antibiotic stewardship involves reframing antimicrobial resistance as an immediate problem with consequences for patients and practitioners(3). Inappropriate antimicrobial prescribing should be seen as a public health threat and a patient safety issue, highlighting the positive effects of targeted prescribing and reducing individual side effects(3).

Opportunities for Antimicrobial Stewardship in Sepsis Management:

Antimicrobial stewardship interventions can be implemented at different stages of sepsis management, including admission, hospitalization, and discharge(1). Strategies such as empirical therapy according to guidelines, de-escalation, switch from intravenous to oral therapy, therapeutic drug monitoring, and restricted antibiotic lists have shown benefits in clinical outcomes, adverse events, and costs(1).

Benefits of Antimicrobial Stewardship in Sepsis:

Improved Patient Outcomes: By ensuring timely and appropriate antimicrobial therapy, antimicrobial stewardship programs contribute to better patient outcomes in sepsis management. This includes reduced mortality rates, decreased length of hospital stay, and improved infection control.

Reduction of Antimicrobial Resistance: Antimicrobial stewardship efforts help mitigate the emergence and spread of antimicrobial resistance. By promoting the judicious use of antimicrobials, these programs minimize selective pressure on bacteria, slowing down the development of resistant strains and preserving the efficacy of available treatment options.

Cost-Effectiveness: Antimicrobial stewardship not only improves patient outcomes but also offers economic benefits. By preventing unnecessary or prolonged antibiotic therapy, ASPs help reduce healthcare costs associated with sepsis treatment while ensuring optimal resource utilization.

Long-Term Sustainability: Addressing antimicrobial resistance through stewardship measures is vital for the long-term sustainability of healthcare systems worldwide. By preserving the effectiveness of existing antimicrobials, ASPs support the development of new antibiotics and innovative treatment strategies for future sepsis cases.

Conclusion:

Improving sepsis outcomes while reducing antibiotic use is a major challenge for critical care physicians. Adherence to local guidelines, multidrug resistance risk assessment, optimized antimicrobial dosing, and integration of rapid diagnostic techniques can aid in achieving this goal(3). Implementing antimicrobial stewardship programs in hospitals is recommended to optimize antimicrobial use, reduce resistance, and decrease rates of Clostridium difficile infection(1).

References:

1. Fitzpatrick F, Tarrant C, Hamilton V, et al. Sepsis and antimicrobial stewardship: two sides of the same coin. BMJ Quality & Safety. 2019;28:758-761.

2. Del Pozo JL. Stewardship in sepsis. Rev Esp Quimioter. 2019 Sep;32 Suppl 2(Suppl 2):42-46. PMID: 31475810; PMCID: PMC675535

3. Michael S. Pulia, Robert Redwood, Brian Sharp, Antimicrobial Stewardship in the Management of Sepsis,Emergency Medicine Clinics of North America,Volume 35, Issue 1,2017, 199-217